Lynch syndrome - Contribution of molecular genetics to the diagnosis of patients not meeting the ICG Amsterdam criteria;Lynchův syndrom - Přénos molekulární genetiky k diagnostice pacientů nesplňujících ICG Amsterdamská kritéria

Ceska a Slovenska Gastroenterologie a Hepatologie

Volumn 57, Issue 2, 2003, Pages 57-60

  Foltin, J ^b   Gutvirthova L ^b   Holy P ^b   Roskot J ^b   Bacigalova M ^b   Cejkova P ^b   Zd'arsky E ^b   Sosna, B ^a   Kment, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Chromosomal instability; DNA diagnosis; Lynch syndrome

Indexed keywords

DNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA DETERMINATION; DNA ISOLATION; FAMILIAL CANCER; HUMAN; MEDICAL SOCIETY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOLECULAR GENETICS; PRACTICE GUIDELINE; QUALITATIVE ANALYSIS; QUANTITATIVE GENETICS; SIBLING;

EID: 0141987721     PISSN: 1213323X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mařatka, Z., a kol. Gastroentrerologie. Praha: Karolinum, 1999, s. 290.
2. Breeze, J. Colorectal cancer. Nurs. Times, 2001, roč. 97, č. 11, s. 39-41.
3. Marti, T. M., Kunz C., Fleck, O. DNA mismatch repair and mutation avoidance pathways. J. Cell. Physiol., 2002, roč. 191, č. 1, s. 28-41. Review.
4. Kruschewski, M., Noske, A., Haier, J., Runkel, N., Anagnostopoulos, Y., Buhr, H. J. Is reduced expression of mismatch repair genes MLH 1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis? Clin. Exp. Metastasis., 2002, roč. 19, č. 1, s. 71-77.
5. Hajer, J., Kepelová, A., Zadorová, Z., Kment, M. Two novel germline mutations (Y548X and K732X) of the MLH1 gene in Czech patients with hereditary nonpolyposis colorectal cancer. Hum. Mutat., 2000, roč. 16, č. 2, s. 181.
6. Kariola, R., Raevaara, T. E., Longvist, K. E., Nystrom-Lahti, M. Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome. Hum. Mol. Genet., 2002, roč. 11, č. 11, s. 1303-1310.
7. Gras, E., Catasus, L., Arguelles, R., Moreno-Bueno, G., et al. Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer, 2001, roč. 92, č. 11, s. 2829-2836.
8. Yuan, Z. Q., Gottlieb, B., Beitel, L. K., et al. Polymorphisms and HNPCC: PMS2-MLH1 protein interactions diminished by single nucleotide polymorphisms, Hum. Mutat., 2002, roč. 19, ̌. 2, s. 108-113.
9. Guarne, A., Junop, M. S., Yang, W. Structure and function of the N-terminal 40 kDa fragment of human PMS2: a monomeric GHL ATPase. EMBO J., 2001, roč. 20, č. 19, s. 5521-5531.
10. Liu, T., Chen, J., Salahshor, S., et al. Screening families with endometrial and colorectal cancers for germline mutations. J. Med. Genet., 2001, rǒ. 38, č. 9, s. E29.
11. Ling, E., Fich, A., Man, S., Wolfson, M., Mikhailowsky, R., Lamprecht, S. A. Detection of tumor mutant APC DNA in plasma of patients with sporadic colorectal cancer. In Vivo, 2000, roč. 14, č. 4, s. 543-546.
12. Ogasa, H., Noma, T., Murata, H., Kawai, S., Nakazawa, A. Cloning of a cDNA encoding the human transforming growth factor-beta type II receptor: heterogeneity of the mRNA. Gene, 1996, roč. 181, č. 1-2, s. 185-190.
13. Fornasarig, M., Viel, A., Bidoli, E., Amsterdam criteria II and endometrial cancer index cases for an accurate selection of HNPCC families. Tumori, 2002, roč. 88, č. 1, s. 18-20.
14. Saeterdal, L., Bjorheim, J., Lislerud, K., et al. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc. Natl. Acad. Sci. U. S. A., 2001, roč. 98, č. 23, s. 13255-13260.
15. Watanabe, T., Wu, T. T., Catalano, P. J., et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N. Engl. J. Med., 2001, roč. 344, č. 16, s. 1196-1206.
16. Lee, H. S., Lee, B. L., Kim, S. H., Woo, D. K., Kim, H. S., Kim, W. H. Microsatellite instability in synchronous gastric carcinomas. Int. J. Cancer, 2001, roč. 91, č. 5, s. 619-24.
17. Wu, T. L., Zhang, D., Chia, J. H., Tsao, K. C., Sun, C. F., Wu, J. T. Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin. Chim. Acta, 2002, roč. 321, č. 1-2, s. 77-87.
18. Shao, Z. M., Nguyen, M. Tumor-specific DNA in plasma of breast cancer patients. Anticancer Drugs, 2002, roč. 13, č. 4, s. 353-7.
19. Silva, J. M., Garcia, J. M., Dominguez, G., et al. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann. Surg. Oncol., 2002, roč. 9, č. 1, s. 71-76.
20. Silva, J. M., Rodriguez, R., Garcia, J. M., et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut, 2002, roč. 50, č. 4, s. 530-534.
21. Gal, S., Fidler, C., Lo, Y. M., et al. Detection of mammaglobin mRNA in the plasma of breast cancer patients. Ann. NY Acad. Sci., 2001, 945, s. 192-194.
22. Lukeš, M., Urban M., Záleský, M., Zachoval, R., Heráček, J., Žd'árský E. Prostate-specific antigen: current status. Folia Biol. (Praha), 2001, roč. 47, č. 2, s. 41-49.
23. Zd'árský, E., Horák, J., Stří teský, J., Heirler, F. Hemochromatosis. Determination of the C282Y mutation frequency in the population of the Czech Republic and sensitivity of hemochromatosis detection using Guthrie cards. Čas. Lek. Čes., 1999, roč. 138, č. 16, s. 497-499. Czech.